Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

Superseded

This Document Has Been Replaced By: Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Updated recommendations for use of meningococcal conjugate vaccines -- Advisory Committee on Immunization Practices (ACIP), 2010

January 28, 2011
By United States. Advisory Committee on Immunization Practices.
Source: MMWR. Morbidity and mortality weekly report. 2011; 60(3):72-6.

[PDF-313.07 KB]

English

Details Related Documents You May Also Like

Details:

Alternative Title:

MMWR. Morbidity and mortality weekly report
Corporate Authors:

United States. Advisory Committee on Immunization Practices.
Description:

On October 27, 2010, the Advisory Committee on Immunization Practices (ACIP) approved updated recommendations for the use of quadrivalent (serogroups A, C, Y, and W-135) meningococcal conjugate vaccines (Menveo, Novartis; and Menactra, Sanofi Pasteur) in adolescents and persons at high risk for meningococcal disease. These recommendations supplement the previous ACIP recommendations for meningococcal vaccination . The Meningococcal Vaccines Work Group of ACIP reviewed available data on immunogenicity in high-risk groups, bactericidal antibody persistence after immunization, current epidemiology, vaccine effectiveness (VE), and cost-effectiveness of different strategies for vaccination of adolescents. The Work Group then presented policy options for consideration by the full ACIP. This report summarizes two new recommendations approved by ACIP: 1) routine vaccination of adolescents, preferably at age 11 or 12 years, with a booster dose at age 16 years and 2) a 2-dose primary series administered 2 months apart for persons aged 2 through 54 years with persistent complement component deficiency (e.g., C5-C9, properidin, factor H, or factor D) and functional or anatomic asplenia, and for adolescents with human immunodeficiency virus (HIV) infection. CDC guidance for vaccine providers regarding these updated recommendations also is included.
Subjects:

[+]

Adolescent Adult Child Child, Preschool Humans Immunization, Secondary Immunization Schedule Meningococcal Infections Meningococcal Vaccines Middle Aged Vaccines, Conjugate Young Adult
Source:

MMWR. Morbidity and mortality weekly report. 2011; 60(3):72-6.
Pubmed ID:

21270745
Document Type:

Journal Article
Place as Subject:

United States
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:07eb368d009272af14f54070e8ec621eb5ae3505458e092033f4f8c3e811c7de
Download URL:

https://stacks.cdc.gov/view/cdc/7457/cdc_7457_DS1.pdf
File Type:

No Additional Files

More +

Control and prevention of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP).

[PDF - 351.06 KB]

:

United States. Advisory Committee on Immunization Practices.

February 14, 1997 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-5):1-10.

Description:

These recommendations update information regarding the polysaccharide vaccine licensed in the United States for use against disease caused by Neisseri...

Status:

superseded

File Type:

[PDF - 351.06 KB]

File Type:

[PDF - 351.06 KB]
Control and prevention of serogroup C meningococcal disease : evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP)

[PDF - 311.86 KB]

:

United States. Advisory Committee on Immunization Practices.

February 14, 1997 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-5):13-21.

Description:

Outbreaks of serogroup C meningococcal disease (SCMD) have been occurring more frequently in the United States since the early 1990s, and the use of v...

Status:

superseded

File Type:

[PDF - 311.86 KB]

File Type:

[PDF - 311.86 KB]

Superseded

Updated recommendations for use of meningococcal conjugate vaccines -- Advisory Committee on Immunization Practices (ACIP), 2010

Details:

Supporting Files

Related Documents

You May Also Like